Cargando…

The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging

Parkinson’s disease (PD), the most common neurodegenerative disorder, is characterized by abnormal accumulation of α-synuclein aggregates known as Lewy bodies (LB) and loss of nigrostriatal dopaminergic neurons. Recent neuroimaging studies suggest that in the early phases of PD, synaptic and axonal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellucci, Arianna, Antonini, Angelo, Pizzi, Marina, Spano, PierFranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641408/ https://www.ncbi.nlm.nih.gov/pubmed/29066967 http://dx.doi.org/10.3389/fnagi.2017.00330

Ejemplares similares

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
por: Faustini, Gaia, et al.
Publicado: (2017)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases
por: Lanzillotta, Annamaria, et al.
Publicado: (2015)

Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism
por: Porrini, Vanessa, et al.
Publicado: (2017)

Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease
por: Bellucci, Arianna, et al.
Publicado: (2011)

Correction: Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease
por: Bellucci, Arianna, et al.
Publicado: (2012)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
por: Longhena, Francesca, et al.
Publicado: (2018)

Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
por: Brembati, Viviana, et al.
Publicado: (2023)

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation
por: Porrini, Vanessa, et al.
Publicado: (2017)

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke
por: Faggi, Lara, et al.
Publicado: (2018)

The beginning and the end
por: Berdiaev, Nikolai, 1874-1948
Publicado: (1952)

The End and the Beginning
Publicado: (1887)

Endings and beginnings
por: Ombelet, W
Publicado: (2016)

The Beginning of the End
Publicado: (1891)

Is It the Beginning of the End?
por: Weir, James
Publicado: (1895)

Correction: Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes
por: Ettorre, Michele, et al.
Publicado: (2012)

Correction: Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes
por: Ettorre, Michele, et al.
Publicado: (2012)

Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes
por: Ettorre, Michele, et al.
Publicado: (2012)

Percutaneous mitral valve repair: the beginning of the end or the end of the beginning?
por: Vahanian, Alec, et al.
Publicado: (2010)

Commentary: January 21, 2020: The beginning of the end or the end of the beginning?
por: Hicks, George L.
Publicado: (2021)

Late-onset Parkinsonism in NFκB/c-Rel-deficient mice
por: Baiguera, Cristina, et al.
Publicado: (2012)

End-to-End Deep Image Reconstruction From Human Brain Activity
por: Shen, Guohua, et al.
Publicado: (2019)

Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine
por: Collo, Ginetta, et al.
Publicado: (2014)

Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2022)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Beginning at the ends: telomeres and human disease
por: Savage, Sharon A.
Publicado: (2018)

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice
por: Parrella, Edoardo, et al.
Publicado: (2019)

Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson’s Disease: A Pilot Study
por: Volpato, Chiara, et al.
Publicado: (2016)

Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease
por: Parrella, Edoardo, et al.
Publicado: (2022)

COPD: The end of the beginning
por: Russell, Richard, et al.
Publicado: (2006)

Trachoma: the beginning of the end?
por: Haddad, Danny
Publicado: (2012)

Onchocerciasis: the beginning of the end?
por: Hopkins, Adrian
Publicado: (2019)

An Ending and a Beginning
por: Amedee, Ronald G.
Publicado: (2019)

JAHA : The End of the Beginning
por: London, Barry
Publicado: (2022)

Manganese-enhanced magnetic resonance imaging reveals light-induced brain asymmetry in embryo
por: Lorenzi, Elena, et al.
Publicado: (2023)

Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist?
por: Heys, Steven D, et al.
Publicado: (2003)

Effects of Exercise on Parkinson’s Disease: A Meta-Analysis of Brain Imaging Studies
por: Li, Jingwen, et al.
Publicado: (2022)

Beginning to See the Light: Lessons Learned From the Development of the Circadian System for Optimizing Light Conditions in the Neonatal Intensive Care Unit
por: Hazelhoff, Esther M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jp8fdflcb0jh93utq50odaaes